Tirzepatide & Weight Maintenance 💊📉
A phase 3 clinical trial (SURMOUNT-4) showed that continued use of tirzepatide helps maintain weight loss in adults with obesity.
Participants on tirzepatide lost an extra 5.5%, while those on placebo regained 14%.
✅ 89.5% maintained at least 80% of their weight loss, compared to 16.6% on placebo.
Common side effects were mild gastrointestinal issues 🤢.
Stopping treatment led to significant weight regain, reinforcing the need for long-term therapy. 🔬
